| Orion Minerals Ltd (ORN) ORDINARY FULLY PAID |
Materials |
$206 |
$0.5 Million Loan Facility
|
23 Jun 2025 9:12AM |
$0.011 |
$0.023 |
risen by
109.09%
|
|
ORN - Price-sensitive ASX Announcement
Full Release
Key Points
- Orion Minerals Ltd secured a $0.5 million loan facility from Tembo Capital Mining Fund II LP and affiliates.
- The loan facility aims to provide working capital for Orion's ongoing development activities.
- Funds will support the Prieska Copper-Zinc Project and Okiep Copper Project in South Africa.
- The loan is unsecured and carries a 12% per annum interest rate.
- Repayment of the loan is due within six months of drawdown.
- The facility helps Orion manage near-term cash flow while pursuing further financing and project progress.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Kingston Resources Limited (KSN) ORDINARY FULLY PAID |
Materials |
$34 |
Gold Concentrate Sales Underway at Mineral Hill
|
23 Jun 2025 9:11AM |
$0.135 |
$0.040 |
fallen by
70.37%
|
|
KSN - Price-sensitive ASX Announcement
Full Release
Key Points
- Kingston Resources Limited has commenced gold concentrate sales at Mineral Hill Mine.
- The new flotation circuit at Mineral Hill has been successfully commissioned.
- First shipments of gold concentrate to offtake partners are underway.
- This development is expected to provide a new revenue stream for the company.
- The gold concentrate sales strengthen Kingston's financial position.
- The flotation circuit enables optimization of value from the Mineral Hill asset.
- The announcement marks a significant operational milestone for Kingston Resources.
- Future shipments and ongoing production are anticipated to continue.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Magellan Financial Group Limited (MFG) ORDINARY FULLY PAID |
Financials |
$1,774 |
Notification of cessation of securities - MFG
|
23 Jun 2025 9:11AM |
$8.410 |
$9.550 |
risen by
13.56%
|
|
| Magellan Financial Group Limited (MFG) ORDINARY FULLY PAID |
Financials |
$1,774 |
Update - Notification of buy-back - MFG
|
23 Jun 2025 9:11AM |
$8.410 |
$9.550 |
risen by
13.56%
|
|
| Regal Investment Fund (RF1) ORDINARY UNITS FULLY PAID |
Financials |
$775 |
Weekly Estimate NTA for 20.06.2025
|
23 Jun 2025 9:10AM |
$2.790 |
$3.720 |
risen by
33.33%
|
|
| Strickland Metals Limited (STK) ORDINARY FULLY PAID |
Materials |
$277 |
Change of Share Registry
|
23 Jun 2025 9:10AM |
$0.140 |
$0.105 |
fallen by
25%
|
|
| Rhythm Biosciences Limited (RHY) ORDINARY FULLY PAID |
Health Care |
$41 |
Board Composition Update Succession Plan
|
23 Jun 2025 9:09AM |
$0.062 |
$0.115 |
risen by
85.48%
|
|
| Whitehaven Coal Limited (WHC) ORDINARY FULLY PAID |
Energy |
$6,957 |
Update - Notification of buy-back - WHC
|
23 Jun 2025 9:09AM |
$5.770 |
$8.450 |
risen by
46.45%
|
|
| Global Uranium and Enrichment Ltd (GUE) ORDINARY FULLY PAID |
Materials |
- |
Global Uranium Appoints Government Advisory Partner
|
23 Jun 2025 9:09AM |
$0.066 |
$0.071 |
risen by
7.58%
|
|
| Smartgroup Corporation Ltd (SIQ) ORDINARY FULLY PAID |
Industrials |
$1,676 |
Change of registered office and principal place of business
|
23 Jun 2025 9:08AM |
$7.220 |
$12.130 |
risen by
68.01%
|
|
| Coast Entertainment Holdings Limited (CEH) ORDINARY FULLY PAID |
Consumer Discretionary |
$190 |
Update - Notification of buy-back - CEH
|
23 Jun 2025 9:07AM |
$0.390 |
$0.490 |
risen by
25.64%
|
|
| Pengana Capital Group Limited (PCG) ORDINARY FULLY PAID |
Financials |
$71 |
Update - Notification of buy-back - PCG
|
23 Jun 2025 9:06AM |
$0.800 |
$0.730 |
fallen by
8.75%
|
|
| Connexion Mobility Ltd (CXZ) ORDINARY FULLY PAID |
Information Technology |
$16 |
Update - Notification of buy-back - CXZ
|
23 Jun 2025 9:05AM |
$0.025 |
$0.023 |
fallen by
8%
|
|
| KKR Credit Income Fund (KKC) ORDINARY UNITS FULLY PAID |
Financials |
$658 |
Net Tangible Asset Backing
|
23 Jun 2025 9:03AM |
$2.250 |
$2.040 |
fallen by
9.33%
|
|
| Regal Investment Fund (RF1) ORDINARY UNITS FULLY PAID |
Financials |
$775 |
Update - Notification of buy-back - RF1
|
23 Jun 2025 9:02AM |
$2.790 |
$3.720 |
risen by
33.33%
|
|
| Golden Horse Minerals Limited (GHM) CHESS DEPOSITARY INTERESTS 1:1 |
Materials |
$99 |
Hopes Hill Diamond Drilling Commences
|
23 Jun 2025 9:01AM |
$0.405 |
$0.455 |
risen by
12.35%
|
|
GHM - Price-sensitive ASX Announcement
Full Release
Key Points
- GHM has commenced diamond drilling at the Hopes Hill prospect.
- The drilling targets high-priority gold mineralisation zones.
- Program aims to collect core samples for geological understanding and resource estimation.
- Recent geological assessments and geophysical surveys have guided the drilling locations.
- Advanced drilling and sampling techniques are being applied.
- The announcement explains the project's geological context and historical exploration significance.
- Program is part of a broader strategy to advance exploration and define resources.
- GHM emphasizes commitment to environmental and community responsibilities.
- Results from the program will inform future drilling and exploration planning.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Lumos Diagnostics Holdings Limited (LDX) ORDINARY FULLY PAID |
Health Care |
$93 |
Lumos Receives Research & Development Tax Rebate
|
23 Jun 2025 9:01AM |
$0.029 |
$0.100 |
risen by
244.83%
|
|
| GTN Limited (GTN) ORDINARY FULLY PAID |
Communication Services |
$35 |
Update - Notification of buy-back - GTN
|
23 Jun 2025 9:00AM |
$0.600 |
$0.185 |
fallen by
69.17%
|
|
| Oceania Healthcare Limited (OCA) ORDINARY FULLY PAID FOREIGN EXEMPT NZX |
Health Care |
$442 |
Meadowbank Presentation
|
23 Jun 2025 9:00AM |
$0.530 |
$0.610 |
risen by
15.09%
|
|
| Hawsons Iron Ltd (HIO) ORDINARY FULLY PAID |
Materials |
$16 |
Share Purchase Plan Offer Booklet
|
23 Jun 2025 9:00AM |
$0.018 |
$0.013 |
fallen by
27.78%
|
|
| X2M Connect Limited (X2M) ORDINARY FULLY PAID |
Information Technology |
$8 |
Secures $3m City of Seoul smart city program contract
|
23 Jun 2025 8:59AM |
$0.019 |
$0.005 |
fallen by
73.68%
|
|
X2M - Price-sensitive ASX Announcement
Full Release
Key Points
- X2M Connect Limited secured a $3 million contract for the City of Seoul's smart city program.
- The contract focuses on deploying IoT solutions for water management and utility efficiency.
- Project highlights X2M's growth and expansion in Asian smart city markets.
- The agreement is expected to bring recurring revenue to X2M.
- X2M's technology will enhance resource management and infrastructure in Seoul.
- This milestone supports X2M's strategy for further expansion in smart infrastructure projects.
- The contract strengthens X2M's reputation and position in the smart city sector.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Mader Group Limited (MAD) ORDINARY FULLY PAID |
Industrials |
$1,636 |
Change of Director's Interest Notice
|
23 Jun 2025 8:57AM |
$5.880 |
$8.040 |
risen by
36.73%
|
|
| PYC Therapeutics Limited (PYC) ORDINARY FULLY PAID |
Health Care |
$1,195 |
FDA Alignment on Registrational Trial Design RP11 Program
|
23 Jun 2025 8:57AM |
$1.150 |
$1.215 |
risen by
5.65%
|
|
PYC - Price-sensitive ASX Announcement
Full Release
Key Points
- PYC Therapeutics has received formal alignment from the U.S. FDA on the registrational trial design for its RP11 program targeting autosomal dominant Retinitis Pigmentosa type 11 (RP11).
- The FDA alignment allows PYC to proceed with a pivotal trial design that may support a New Drug Application (NDA) submission, pending successful outcome.
- The trial will be a randomized, masked, controlled study evaluating the efficacy, safety, and tolerability of PYLA-101, PYC’s lead candidate, in patients with genetically confirmed PRPF31-associated RP11.
- Primary efficacy endpoint agreed with the FDA is the change from baseline in best-corrected visual acuity (BCVA) at 12 months.
- Secondary endpoints include visual field sensitivity and patient-reported outcomes relating to visual function and quality of life.
- FDA alignment provides a clear path forward for PYC’s clinical development of PYLA-101 and de-risks the regulatory pathway for the RP11 program.
- PYC intends to initiate the registrational trial in 2024, subject to finalization of operational planning and institutional review board approvals.
- The company’s broader pipeline includes novel RNA therapeutics for inherited retinal diseases, with additional candidates progressing toward clinical evaluation.
- PYC continues to engage with key opinion leaders, patient advocacy groups, and regulatory stakeholders to ensure robust trial design and patient-centric outcomes.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Adairs Limited (ADH) ORDINARY FULLY PAID |
Consumer Discretionary |
$234 |
ADH Trading Update and FY25 Guidance
|
23 Jun 2025 8:56AM |
$2.580 |
$1.310 |
fallen by
49.22%
|
|
ADH - Price-sensitive ASX Announcement
Full Release
Key Points
- Trading conditions remain challenging due to cost-of-living pressures affecting consumer demand.
- FY24 group sales are expected to decline modestly year-on-year.
- Underlying EBIT for FY24 is forecast to be lower than the prior year.
- Improved margins are anticipated in FY25 through strategic initiatives.
- Focus areas include inventory optimization, cost control, and supply chain enhancements.
- Online channel growth and product range expansion are key strategic objectives.
- Adairs is committed to disciplined capital management for sustainable growth.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Regal Asian Investments Limited (RG8) ORDINARY FULLY PAID |
Financials |
$408 |
Weekly NTA Update
|
23 Jun 2025 8:55AM |
$1.900 |
$2.850 |
risen by
50%
|
|